Is Makers Labs. overvalued or undervalued?
As of November 10, 2025, Makers Labs. is considered overvalued with a PE ratio of -4693.22, unfavorable comparisons to peers like Sun Pharma and Cipla, and a significant year-to-date stock decline of 34% versus the Sensex's gain of 6.91%.
As of 10 November 2025, the valuation grade for Makers Labs. has moved from very attractive to very expensive. This indicates a significant shift in the company's perceived value, suggesting that it is currently overvalued. The company's PE ratio stands at an alarming -4693.22, while its EV to EBITDA is 8.94 and EV to Sales is 0.66, which are concerning figures in the context of its financial health.In comparison to its peers, Makers Labs. is positioned unfavorably against companies like Sun Pharma. Inds., which has a PE ratio of 35.15 and an EV to EBITDA of 10.64, and Cipla, which boasts a PE ratio of 22.45 and an EV to EBITDA of 5.67. The stark contrast in these ratios highlights the overvaluation of Makers Labs. Furthermore, the company's stock has underperformed the Sensex significantly over various periods, with a year-to-date decline of 34.00% compared to the Sensex's gain of 6.91%. Overall, the evidence strongly supports that Makers Labs. is overvalued in the current market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
